Targeting olfactory receptor OR2AT4: An innovative aptamer-based treatment for hair growth promotion靶向嗅觉受体OR2AT4:一种创新性的基于适配体的促进毛发生长的治疗方法Molecular Therapy Nucleic AcidsIF6.12025-06-160OAAI
FPR2 DNA Aptamers for Targeted Therapy of Wound RepairJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72022-08-013OAAI
Immunotherapeutic effect of adenovirus encoding antimicrobial peptides in experimental pulmonary tuberculosisJOURNAL OF LEUKOCYTE BIOLOGYIF3.12021-03-0810PREAI
Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa: A Case ReportFRONTIERS IN MEDICINEIF32020-11-2611OAAI
The importance of immunity in the development of reliable animal models for psoriasis and atopic dermatitisIMMUNOLOGY AND CELL BIOLOGYIF32020-07-1513OAAI
Oxidative stress imbalance as contributing factor in the establishment of fibrosis in recessive dystrophic epidermolysis bullosaJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72019-09-012OAAI
Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual sgRNA CRISPR/Cas9-Mediated Gene EditingMOLECULAR THERAPYIF122019-05-0177OAAI
CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa PatientMOLECULAR THERAPYIF122018-11-0149OAAI
Olfactory receptors in skin. Localization, specific expression pattern and their potential role in wound healingJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72017-10-010OAAI
Comparative transcriptomic analysis of fibroblasts from two sisters with discordant severe generalized recessive dystrophic epidermolysis bullosa phenotype reveals new molecular markers associated with disease severityJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72017-10-010OAAI
Differential Features between Chronic Skin Inflammatory Diseases Revealed in Skin-Humanized Psoriasis and Atopic Dermatitis Mouse ModelsJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72016-01-0142OAAI
Targeted silencing of DEFB4 in a bioengineered skin-humanized mouse model for psoriasis: development of siRNA SECosome-based novel therapiesEXPERIMENTAL DERMATOLOGYIF3.12014-03-0752PREAI
Assessment of optimal virus-mediated growth factor gene delivery for human cutaneous wound healing enhancementJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72008-06-0150OAAI
In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37JOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72008-01-01323OAAI
Modeling normal and pathological processes through skin tissue engineeringMOLECULAR CARCINOGENESISIF3.22007-07-0338PREAI
Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I moleculesIMMUNOLOGICAL REVIEWSIF8.32006-04-28126OA
A cutaneous gene therapy approach to treat infection through keratinocyte-targeted overexpression of antimicrobial peptidesFASEB JOURNALIF4.22004-09-2953PREAI
Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factorCANCER RESEARCHIF16.62004-08-1697OAAI
An intermediate-purity factor VIII concentrate supports platelet adhesion under flow conditionsHAEMOPHILIAIF32003-10-306PREAI
The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals -: Functional roles of NF-κB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoterJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92001-09-0189OAAI